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httpcense.Abstract The association between allergic and psychological disorders had been reported, but
whether the key mediating ingredients are predominantly biological, psychological, or mere arti-
facts remains unknown. We aim to examine the relationship between objectively measured atopic
status and anxiety, depression, and neuroticism.
Methods: This randomized case controlled trial was conducted on 50 atopic patients and 50
healthy controls. Atopy was determined by skin prick test and allergy related symptoms. Psycho-
logical assessment was done using Beck Depression Inventory (BDI) for the level of depression,
the State-Trait Anxiety Inventory (STAI) for anxiety level, while Middle Sex Hospital Question-
naire (MHQ) for measurement of neuroticism. Serum total IgE level was detected in both groups.
Results: 100 individuals were enrolled (50 atopic patients and 50 healthy control subjects) with a
mean age (28.24 ± 9.74) and (32.60 ± 8.23) respectively. The mean STAI score for both state and
trait anxiety was signiﬁcantly higher in atopic versus non-atopic (p= 0.000) while the mean BDI
score was higher in atopic than non-atopic patients but without statistical signiﬁcance. Also, there
was no signiﬁcant difference in the mean MHQ scores (for hysteria, depression, obsession, somatic
anxiety, phobic anxiety and free-ﬂoating anxiety) in atopic versus non-atopic groups. There was no
correlation between the mean STAI, BDI, and MHQ scores and the mean value of total IgE levels
in atopic patients.000700390; fax: +20 050223
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300 A. Fathy et al.Conclusion: Atopic patients are more likely to have both state and trait anxiety than non-atopic.
So, it might be considered in management plan of atopic patients.
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Several epidemiological and clinical studies have examined the
relationships between various psychosocial factors and allergic
diseases, predominantly asthma [1,2]. Some of the studies
examined the relationships between allergic diseases and vari-
ous personality traits, such as neuroticism [3,4], anxiety [5,6],
and depression [7]. The co-occurrence of an anxiety or depres-
sive disorder has been shown to be associated with adverse
outcomes such as poor symptom control, increased health care
utilization, and impaired quality of life (QOL) in adult asth-
matic patients.
Nowadays, the studies of their relationship can be viewed
from the standpoint of the biopsychosocial model of disease
[1–5]. The model postulates that one needs to take into consid-
eration the interaction between biological, psychological, and
social factors to be able to understand different disease out-
comes, i.e. vulnerability to disease, disease onset, expression
of symptoms, disease progression, exacerbation, recovery, sur-
vival, and associated quality of life [8].
The majority of studies performed till now have examined
the association between psychosocial factors and allergic dis-
eases, and did not attempt to distinguish between asymptom-
atic atopic constitution and allergy symptoms. Atopy is
deﬁned as a personal and/or familial tendency, usually in child-
hood or adolescence, to become sensitized and produce IgE
antibodies in response to ordinary exposures to allergens. Ato-
py should be documented by objective markers, i.e. IgE anti-
bodies in serum or by a positive skin prick test. A person of
the atopic constitution may develop typical allergic symptoms
of asthma, rhinoconjuctivitis, or eczema [9].
So we are aiming to investigate the hypothesized associa-
tion between the atopic status and psychological disorders
especially neuroticism depression, and anxiety. Also, whether
it differs if the patient had multiple allergen sensitivity, multi-
ple atopic phenotyping or not.
Subjects and methods
After approval by the Medical Research Ethics Committee,
Mansoura University, Egypt, 50 atopic patients with ages
ranging from 18 to 54 years and 50 healthy non-atopic subjects
with age range from 22 to 50 years were enrolled in this study.
The atopic patients were further subdivided into bronchial
asthma (BA) alone and BA associated with symptoms of other
atopic diseases allergic rhinitis, allergic conjunctivitis and ato-
pic dermatitis. All patients’ diagnoses were conﬁrmed by chart
review and veriﬁed by treating physician. Exclusion criteria; if
the patients had an apparent cognitive deﬁcit or mental defect
or if they had a signiﬁcant chronic medical conditions that
conferred a greater risk for morbidity (e.g. COPD, CHD,. . .).
All patients were recruited from consecutive patients to the
allergy and immunology unit in the chest department, Manso-
ura University Hospital from April to September 2013.A questionnaire including general data and medical history
was completed by a physician for each subject. Data about a
history of pulmonary, nasal, eye and skin symptoms due to al-
lergy were also collected. All patients were subjected to skin
prick testing, and a blood samples were collected for detection
of total IgE levels.
Skin prick test
Skin prick testing (SPT) was performed using a standard meth-
od [10] with a panel of common local allergens. SPT included
testing with positive control solution (10 mg mL1 of hista-
mine hydrochloride) and negative control solution (buffer
solution). Skin reaction (wheal) was evaluated after 15 min.
The mean skin reaction (mean wheal diameter) was calculated
according to the formula (D+ d)/2, where D represented the
largest longitudinal diameter and d its midpoint orthogonal
diameter in mm. For statistical evaluation of the SPT results,
the difference between mean skin reaction to each allergen
and negative control solution was used as a parameter of
SPT reactivity. The results of SPT were considered positive
when the mean wheal diameter was larger than the negative
control for 3 mm or more in at least one tested allergen.Psychological assessment
Depression level
Level of depression was evaluated with the Beck Depression
Inventory (BDI) [11]. The participants were required to answer
21 questions and each answer was scored on a scale from 0 to
3. The BDI overall score corresponds to the depression levels
in a given individual, with higher overall scores indicative of
more severe depressive symptoms. The individual is considered
free from depression if the overall score is 9 points or less,
mildly depressed from 10 to 18, moderately depressed from
19 to 29 and severely depressed if 30 or more.
Levels of trait anxiety and state anxiety
Anxiety level was determined using the State-Trait Anxiety
Inventory (STAI), which examines anxiety as a transient state
(X-1 questionnaire) and a relatively stable personality trait (X-2
questionnaire) [12]. Each questionnaire consists of a 20-question
inventory, with answers scored from 1 to 4. Higher overall scores
suggest higher levels of anxiety. The level of anxietywas classiﬁed
as follows: mild < 30, moderate from 30 to 50, and severe > 50.
Middle Sex Hospital Questionnaire (MHQ)
The MHQ test was designed for providing a measure of
neuroticism. It is a 48 item Questionnaire covering six
neurotic manifestations (free-ﬂoating anxiety, phobic anxiety,
Table 2 STAI, BDI, MHQ scores for atopic patients versus
healthy non-atopic.
Atopic patients
(n= 50)
Non-atopic control
(n= 50)
P Value
STAI scores
State anxiety 47.66 ± 4.35 24.40 ± 5.01 0.000
Trait anxiety 38.10 ± 7.03 16.33 ± 7.21 0.000
BDI score 9.84 ± 10.70 7.60 ± 5.58 0.223
MHQ scores
Hysteria 6.60 ± 2.56 6.40 ± 3.34 0.764
Depression 8.90 ± 3.34 8.80 ± 2.71 0.890
Somatic A 8.02 ± 3.37 7.13 ± 4.12 0.298
Obsession 9.12 ± 2. 9.27 ± 2.91 0.814
Phobic A 7.28 ± 2.58 8.07 ± 3.03 0.220
Free-ﬂoating A 6.68 ± 3.79 5.67 ± 4.05 0.262
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and hysteria). For each question, give (2) for yes, (1) for some-
times and (0) for no. Scores above 12 will conﬁrm neuroticism,
scores between 12 and 8 will indicate suspicious neuroticism
while scores below 8 will indicate normality [13].
Statistical analyses
Statistical analysis included the Mann–Whitney U test the
Kruskal–Wallis test and Pearson’s chi-square test. Power and
direction of relationships between 2 continuous variables were
determined using Spearman’s rank coefﬁcient of correlation
(R). Signiﬁcance of relationships between the pairs of discrete
variables was veriﬁed with Pearson’s chi-square test. For con-
tinuous variables, mean and standard deviation were calcu-
lated, while for categorical data (e.g. IgE positivity)
proportions were computed. Mann–Whitney U test was used
for the grouping factor gender (male, female). In all analyses,
p values of less than 0.05 were considered signiﬁcant. All calcu-
lations were carried out using the SPSS (version 15).
Results
In this study, 100 individuals were enrolled (50 atopic patients
and 50 non-atopic healthy control subjects). The mean age of
atopic patients was 28.24 ± 9.74 and the mean age of healthy
non-atopic healthy control was 32.60 ± 8.23. From the 50 ato-
pic patients 11 had asthma alone and 39 had asthma associated
with symptoms of other atopic diseases; 36 patients show
symptoms of allergic rhinitis (AR), 19 patients show symptoms
of atopic dermatitis (AD) and 23 patients show symptoms of
allergic conjunctivitis (AC). The non-atopic controls had sig-
niﬁcantly higher means of age (p= 0.044), socioeconomic le-
vel (p= 0.006), while the atopic patients had signiﬁcantly
higher mean value of serum total IgE level (p= 0.000) as dem-
onstrated in Table 1. The mean STAI score for both state and
trait anxiety was signiﬁcantly higher in atopic patient group
than healthy non-atopic control group (p= 0.000). Also the
depression score (mean BDI score) of atopic patient group
was also higher than healthy non-atopic but without statisticalTable 1 Sociodemographic data and total IgE of the atopic
and non-atopic groups.
Atopic patients
(n= 50)
Non-atopic
control (n= 50)
P Value
Age (mean ± SD) 28.24 ± 9.74 32.60 ± 8.23 0.044
Gender
Male 23(46%) 28(56%)
Female 27(54%) 22(44%) 0.159
Marital status
Married 22(44%) 18(36%) 0.166
Single 28(56%) 32(64%)
Education
Primary 6(12%) 16(32%)
Secondary 26(52%) 8(16%) 0.684
Higher 18(36%) 26(52)
Socioeconomic level
(mean ± SD)
15.82 ± 6.46 20.20 ± 7.11 0.006
Value of total IgE level
(mean ± SD)
226.17 ± 85.71 70.16 ± 29.49 0.000signiﬁcance. Meanwhile, there was no signiﬁcant difference in
the mean MHQ scores (for hysteria, depression, obsession, so-
matic anxiety, phobic anxiety and free-ﬂoating anxiety) in ato-
pic versus non-atopic groups as demonstrated in Table 2. As
regards the effect of gender, in case of atopic patients it was
obvious that the mean STAI, BDI and MHQ scores were high-
er in women than men but this was signiﬁcant only in case of
trait anxiety (p= 0.018), MHQ score for depression
(p= 0.022) and somatic anxiety (p= 0.015) as shown in
Table 3.
Considering the dose–effect of symptoms of multiple atopic
diseases or poly-allergens (as demonstrated in SPT) there was
no signiﬁcant difference in the mean STAI, BDI, and MHQ
scores in the group of asthma alone and the group of asthma
associated with symptoms of other atopic diseases as well as in
case of mon-allergic and poly-allergic patients (according to
SPT result) (data not shown).
Table 4 shows that, irrespective of the level of IgE (normal
or high) in atopic patients the mean STAI score for both state
and trait anxiety was still signiﬁcantly higher in atopic patient
subgroups than healthy non-atopic control group (p= 0.000),
while there was no statistical signiﬁcant difference between the
mean STAI, BDI, and MHQ scores and the mean value of ser-
um total IgE levels in atopic subgroups and the non-atopic
groups.Table 3 The mean STAI, BDI, MHQ score difference
according to gender in atopic patients.
Male atopic
patients (n= 23)
Female atopic
patients (n= 27)
P Value
STAI scores
State anxiety 48.65 ± 2.72 46.81 ± 5.27 0.122
Trait anxiety 35.65 ± 5.11 40.19 ± 7.83 0.018
BDI score 9.48 ± 11.01 10.15 ± 10.07 0.828
MHQ scores
Hysteria 6.00 ± 2.95 7.11 ± 2.10 0.128
Depression 7.74 ± 3.22 9.07 ± 3.17 0.022
Somatic A 6.78 ± 2.56 9.07 ± 3.65 0.015
Obsession 9.00 ± 2.66 9.22 ± 2.49 0.762
Phobic A 6.52 ± 2.15 7.93 ± 2.77 0.054
Free-ﬂoating A 5.61 ± 3.17 7.59 ± 4.08 0.064
Table 4 Comparison of mean STAI, BDI, MHQ score between atopic patients with normal IgE, atopic with high IgE, and in non-
atopic control groups.
Atopic patients
With normal IgE (n= 28)
Atopic patients with
high IgE (n= 22)
Non-atopic
control (n= 50)
P Value
STAI scores
State anxiety 47.66 ± 4.35 47.28 ± 5.43 24.40 ± 5.01 0.000
Trait anxiety 38.14 ± 7.27 38.05 ± 6.89 16.33 ± 7.21 0.000
BDI score 10.50 ± 10.67 9.00 ± 10.92 7.60 ± 5.58 0.488
MHQ scores
Hysteria 6.46 ± 2.33 6.77 ± 2.88 6.40 ± 3.34 0.892
Depression 9.63 ± 3.83 8.32 ± 3.55 8.80 ± 2.71 0.502
Somatic A 8.68 ± 3.60 7.18 ± 2.91 7.13 ± 4.12 0.209
Obsession 9.36 ± 2.61 8.82 ± 2.48 9.27 ± 2.91 0.761
Phobic A 7.46 ± 2.69 7.05 ± 2.48 8.07 ± 3.03 0.411
Free-ﬂoating A 7.04 ± 4.19 6.23 ± 3.25 5.67 ± 4.05 0.411
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The relationship between allergic disorders and various psy-
chosocial factors has been studied extensively. However, there
are few studies that examined the associations between objec-
tively measured atopy and psychosocial factors [2]. Our study
has attempted to give further insight in these associations by
examining the relationship between atopy determined on the
basis of the skin prick test, and neuroticism, exposure to stress-
ful life events, and subjective quality of life, measured with
questionnaires.
This study was designed to evaluate psychosocial features
of allergic patients with objectively measured atopy. 100 indi-
viduals were enrolled, 50 atopic patients and 50 non-atopic
control subjects. The non-atopic controls had signiﬁcantly
higher means of age (p= 0.044), socioeconomic level
(p= 0.006) while the atopic patients had signiﬁcantly higher
mean value of serum total IgE level (p= 0.000).
It was found that, anxiety scores (mean STAI scores) for
both state and trait anxiety were signiﬁcantly higher in atopic
than non-atopic patients (p= 0.000), and also signiﬁcantly
higher in atopic female than male (p= 0.018), this ﬁnding
was similar to that reported by Postolache et al. 2008 [14] as
they found that anxiety scores were higher in allergic patients
(p< 0.04) while Klokk et al. [15] did not ﬁnd any relationship
between atopy, i.e. level of IgE, and symptoms of anxiety in
women and men.
Based on those results, the authors did not doubt that there
in fact was an association between anxiety and depression and
allergic diseases, but they questioned the relevance of IgE as a
common factor in that association. Similarly, in our study we
did not ﬁnd a signiﬁcant association of depression with atopy
(i.e. positive skin prick test). The ﬁndings of an association be-
tween atopy and development of life-time depression in some
studies [16,17] do not contradict our ﬁnding, as no signiﬁcant
difference was observed in the depression score (mean BDI
score) between atopic patients and non-atopic subjects. How-
ever, our results were in accordance with those reported by
Slattery and Essex [18], by Goodwin and Buka [19], and Katon
et al. [20] as they found that only anxiety but not depression
was associated with atopic disorders.
In this study, we use the Middle Sex Hospital Questionnaire
(MHQ) to evaluate neuroticism and there was no observed sig-niﬁcant difference in the mean MHQ score between the atopic
patients and non-atopic subjects for any of the components of
this questionnaire (hysteria, depression, somatic anxiety,
obsession, panic anxiety and free-ﬂoating anxiety). Our ﬁnd-
ings were similar to that reported by Radosˇevic´-Vidacˇek,
et al. [21] as they found that atopic subjects did not show high-
er levels of neuroticism in comparison to non-atopic and were
opposite to Mehrinejad et al. [22] who reported that atopic pa-
tients showed higher level in neuroticism than non-atopic ones.
While in a study of self-reported asthma diagnosis in adult
population, higher levels of neuroticism were related to higher
prevalence of asthma, but no such relationship was observed
with the incidence of asthma [23]. In a cross-sectional study
of self-reported allergy in adult population [24], higher levels
of neuroticism were associated with increased likelihood of
diagnosed allergy. This association was speciﬁc for men. The
results of these studies indicate that the relationship between
neuroticism might be gender speciﬁc, and that neuroticism
was not relevant for the aetiology of allergic disorders.
In this study the effect of gender was observed specially in
case of trait anxiety and MHQ scores; as females were signiﬁ-
cantly higher than males in the mean scores of trait anxiety
(p= 0.018), MHQ scores of depression (p= 0.022), and so-
matic anxiety (p= 0.015). Also, the mean MHQ scores in
other components of neuroticism were higher in women than
men but not statistically signiﬁcant. Similarly the effect of gen-
der on neuroticism was observed by Mehrinejad et al. [22] as
there was a signiﬁcant relationship between psychasthenia
(p< 0.04), depression (p< 0.006), conversional hysteria
(p< 0.01), masculinity–femininity (p< 0.01), and hypochon-
driasis (p< 0.002). The mean score in women was signiﬁcantly
higher than men.
In this study there was no correlation between the mean va-
lue of serum total IgE levels and the mean scores for neuroti-
cism and depression in atopic patients while there was a
statistical signiﬁcant increase of both state and trait anxiety
in atopic patients with either normal or high IgE. This ﬁnding
was similar to that reported by Klokk et al. [15] as they did not
ﬁnd any relationship between level of IgE, and symptoms of
anxiety/depression in women. Also, Postolache et al. [14]
found that the IgE speciﬁc tree pollen positivity was not signif-
icantly associated with changes in anxiety scores. On the other
hand, Manalai et al. [25] found that allergen-speciﬁc IgE
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depressive scores during exposure to aeroallergens (p= 0.01).
The current study may be conceptually important as one
could suppose that identifying a relationship between both
state and trait anxiety and atopic status strongly suggests a
relationship that may affect both. According to this concept,
we may need to investigate more the causality, triggering, pre-
cipitation, and exacerbation of anxiety disorders that are
important for designing potential preventive and curative
interventions.
Additional research is necessary to conﬁrm our currently
reported relationship between both state and trait anxiety
and atopic status, with better instruments for measuring anxi-
ety and more precise measurements of allergic inﬂammation.
More studies in humans and animals, involving immunological
and psychotropic interventions, will be essential for mechanis-
tic and therapeutic understanding and may contribute to the
generation of novel targets and interventions for anxiety symp-
toms and allergic disorders.
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